Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hybrid CATT1: Cadisegliatin in T1D Patients Using Hybrid Closed Loop Systems
NCT07616206Phase 2Not yet recruiting
- Sponsor
- vTv Therapeutics
- Start
- Oct 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 2 trial of cadisegliatin in type 1 diabetes mellitus (T1D), sponsored by vTv Therapeutics. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
cadisegliatin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT07616206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07616206.